About us|Cardiac Arrest|LUCAS CPR|For users|News & Media|Contact|

News archive

LUCAS automated CPR more effective than manual CPR in cardiac arrest patients

November 25, 2009, Lund, Sweden

Data presented at the American Heart congress show significantly improved end-tidal carbon dioxide levels in cardiac arrest patients who received LUCAS mechanical chest compressions.

Mechanical chest compressions during cardiopulmonary resuscitation (CPR) seem to significantly improve the circulation in cardiac arrest patients compared to manual chest compressions, according to research presented at the American Heart Association (AHA) congress in Orlando, US this week. The cluster-randomized clinical study of out-of-hospital cardiac arrest patients, by Christer Axelsson and colleagues at Sahlgrenska University Hospital and the EMS system in Gothenburg, Sweden, confirms results from experimental studies that LUCAS Chest Compression System increases the end-tidal carbon dioxide values significantly compared to manual chest compressions. End-tidal carbon dioxide is a surrogate indicator for blood circulation.

“In our study of a high-risk group of out-of-hospital cardiac arrest patients, LUCAS improved end-tidal carbon dioxide values significantly. This measurement is known to correlate well to circulation such as cardiac output as well as return of spontaneous circulation. LUCAS is simply doing the job better than we do manually”, says Christer Axelsson, RN, AN, PhD Stud. at the Gothenburg EMS system in Sweden.

“How to improve the quality of CPR has been a hot topic in resuscitation for a long time now. We know that LUCAS mechanical chest compression system is an easy-to-use and practical tool that facilitates life-saving while ensuring safety of our customers, the professional rescuers. It is very satisfying to see the steady growing pool of human data continue to confirm the basics; clinical safety and CPR effectiveness of the LUCAS device”, says Erik von Schenck, CEO of Jolife AB, the manufacturer of LUCAS Chest Compression System.

The study which is made on the pneumatic LUCAS 1 (model V1) is published in the latest issue of Resuscitation 2009 Oct;80(10):1099-103.

LUCAS Chest Compression System is an easy-to-use and lightweight device that provides quality chest compressions according to the European Resuscitation Council and American Heart Association Guidelines for CPR (cardiopulmonary resuscitation). It assists rescuers in maintaining vital blood circulation in cardiac arrest patients. LUCAS is simple to use, applied within seconds and feasible for use in a majority of cardiac arrest patients. LUCAS is available in an electrically driven version (LUCAS 2) and a pneumatically driven (LUCAS 1). The mechanical CPR device has shown to increase operational efficacy and to improve the opportunities to save cardiac arrest patients.

About Jolife AB
Jolife AB, founded in 2000, develops and manufactures the LUCAS Chest Compression System. Jolife works closely with leading physicians and paramedics and is committed to research and development in order to continue to offer innovative products. The LUCAS Chest Compression Systems are sold in the major markets in the world. Based in Lund in southern Sweden, Jolife markets its products through an exclusive global distribution agreement with Physio-Control, Inc., a division of Medtronic Inc. – except in Sweden, Norway and Finland, where Jolife sells directly.

Further information:
Erik von Schenck, CEO, JOLIFE
Tel: +46 46 286 5002
E-mail: evs@jolife.com


Sara Lindroth, Marketing Director, JOLIFE
Tel: +46 46 286 5024
E-mail: sara.lindroth@jolife.com

Jolife AB
Scheelevägen 17
223 70 Lund
Tel: +46 46 286 5000

Latest news
Train on LUCAS™

Physio-Control Inc. / Jolife AB, Ideon Science Park, SE-223 70 Lund, Sweden, Tel: +46 (0) 46 286 50 00, Fax: +46 (0) 46 286 50 10, info@lucas-cpr.com
Powered by Publiciteta&Co